Guideline for the prophylactic use of Rh D immunoglobulin in pregnancy care released

The Guideline for the prophylactic use of Rh D immunoglobulin in pregnancy care is intended to guide health care professionals in making clinical decisions about the prophylactic use of Rh D immunoglobulin in Rh D negative pregnant women in accordance with scientific evidence and consensus among clinical experts. Electronic copies of the Guideline can be downloaded from the National Blood Authority’s website at www.blood.gov.au/anti-d-0. A summary of the clinical guidance, adaptable care pathways and a technical report describing the evidence review process are also available on the website.